ThV-02

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameThV-02

Drug Alias Nameanti-HTLV1 immunotherapy (Theravectys)recombinant lentiviral gene vector-based therapeutic vaccine (THERAVECTYS)anti-human T-cell lymphotropic virus immunotherapy (Theravectys)

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsLeukemia, T-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTheravectys Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTheravectys Sa

Active IndicationsN/A

Inactive IndicationsLeukemia, T-Cell

Other Information

ATC CodeN/A